Introducing the Test post

I’m excited to share our latest free feature: The Psychedelic News Feed. This webpage aims to serve as a one-stop destination for the latest media coverage of psychedelics business, policy, research and beyond. No aggregators, no AI bots: we manually accumulate these clippings and sprinkle in some quick-take analysis here and there. We will also send a weekly digest of the Psychedelic News Feed to…

Source

Hamas strikes could impact some biopharma operations in Israel

Several biotechs and pharma companies have issued statements clarifying the impact of Saturday’s attacks in Israel on their workers and operations. Some of the first

October 10, 2023

Advanced imaging reveals hidden vision loss in AMD

New research by the University Hospital Bonn (UKB) in cooperation with the University of Bonn has shown for the first time that certain early changes

July 11, 2024

Tezepelumab by Amgen for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.